Bluejay Diagnostics Accounts Payable

Bluejay Diagnostics (BJDX) currently reports a accounts payable of $220K as of March 2026. That compares with $520K in the prior-year period — down 57.6% year over year. Use the charts on this page to explore Bluejay Diagnostics's accounts payable history and peer comparisons.

Bluejay Diagnostics's accounts payable decreased from $520K to $220K — a 57.6% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bluejay Diagnostics reported $220K in accounts payable as of March 2026. That compares with $520K in the prior-year period — down 57.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $220K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bluejay Diagnostics, and consider following BJDX for alerts when major investors trade the stock.